Back to search

University of Peloponesse

Αξιολόγηση της προγνωστικής και διαγνωστικής απόδοσης των κλιμάκων SIRS, MEWS, NEW52 και qSOFA ως προς τη σήψη σε ασθενείς ΤΕΠ με υποψία λοίμωξης και ο ρόλος των νοσηλευτών στην εφαρμογή τους.

Abstract

dc:description

Introduction: Sepsis is one of the most urgent and life-threatening conditions encountered in Emergency Departments (EDs). Its early recognition during triage is critical for the timely initiation of therapeutic interventions and for improving patient outcomes. Several scoring systems, such as SIRS, MEWS, NEWS2 and qSOFA, are used for this purpose; however, they differ in their prognostic and diagnostic performance.Aim: The aim of this doctoral dissertation was to evaluate the prognostic and diagnostic performance of the SIRS, MEWS, NEWS2 and qSOFA scores in ED patients with suspected infection. In addition, the study examined the contribution of selected biomarkers, the value of modified scoring models, independent risk factors, and nurses’ views regarding the implementation of these tools in clinical practice.18Methodology: The study included both quantitative and qualitative components. The quantitative component was a prospective observational study of ED patients with suspected infection. During the 12-month study period, 918 patients were assessed, of whom 530 were included in the final analysis. Diagnostic and prognostic accuracy indices were calculated, including sensitivity, specificity, PPV, NPV and AUROC, while AUROC comparisons were performed using the DeLong method. NRI and McNemar’s test were used to evaluate modified scoring models. In the qualitative component, semi-structured interviews were conducted with 12 ED nurses and thematic analysis was applied.Results: The mean age of the patients was 63.7 years, and 51.3% were women. The 28-day in-hospital mortality rate was 8.7%, while 4.3% of patients required an ICU stay of ≥3 days. NEWS2 showed consistently high sensitivity and NPV, making it particularly useful for ruling out low-risk patients. In contrast, qSOFA demonstrated higher specificity and PPV, making it more suitable for identifying high-risk patients. SIRS and MEWS generally showed lower overall performance. The addition of biomarkers resulted in some statistically measurable improvements, mainly in the prediction of 28-day mortality, although these did not always translate into clear clinical benefit. Age ≥65 years emerged as an independent risk factor for 28-day mortality. In the qualitative component, four themes were identified: the conceptual and clinical basis of sepsis recognition, the relationship between experiential judgement and standardized tools, the transition from assessment to practice, and the prerequisites for more effective triage.Conclusions: NEWS2 and qSOFA showed better overall performance than SIRS and MEWS, but they serve different clinical purposes. NEWS2 appears more appropriate for the early exclusion of low-risk patients, whereas qSOFA is more useful for identifying high-risk patients. Biomarkers may serve as complementary tools but cannot replace clinical scoring systems. Effective recognition of sepsis in the ED requires a combination of standardized tools, clinical judgement, nursing experience, education and organizational support.

Degree

thesis:*
Grantor dc:publisher
University of Peloponesse
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Xythalis, Dimitrios
  • Ξυθάλης, Δημήτριος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/62499

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Xythalis, Dimitrios; Ξυθάλης, Δημήτριος. Αξιολόγηση της προγνωστικής και διαγνωστικής απόδοσης των κλιμάκων SIRS, MEWS, NEW52 και qSOFA ως προς τη σήψη σε ασθενείς ΤΕΠ με υποψία λοίμωξης και ο ρόλος των νοσηλευτών στην εφαρμογή τους.. University of Peloponesse, 2026. http://hdl.handle.net/10442/hedi/62499